P1113: COMPARATIVE EFFICACY OF ZANUBRUTINIB (ZANU) VERSUS RITUXIMAB (RTX) IN RELAPSED MARGINAL ZONE LYMPHOMA (MZL): MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)

Detalles Bibliográficos
Autores principales: Thieblemont, Catherine, Wang, Kaijun, Keeping, Sam, Zhang, Ina, Yang, Keri, Tang, Boxiong, Mohseninejad, Leyla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431069/
http://dx.doi.org/10.1097/01.HS9.0000971348.10013.c4
_version_ 1785091111956512768
author Thieblemont, Catherine
Wang, Kaijun
Keeping, Sam
Zhang, Ina
Yang, Keri
Tang, Boxiong
Mohseninejad, Leyla
author_facet Thieblemont, Catherine
Wang, Kaijun
Keeping, Sam
Zhang, Ina
Yang, Keri
Tang, Boxiong
Mohseninejad, Leyla
author_sort Thieblemont, Catherine
collection PubMed
description
format Online
Article
Text
id pubmed-10431069
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104310692023-08-17 P1113: COMPARATIVE EFFICACY OF ZANUBRUTINIB (ZANU) VERSUS RITUXIMAB (RTX) IN RELAPSED MARGINAL ZONE LYMPHOMA (MZL): MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) Thieblemont, Catherine Wang, Kaijun Keeping, Sam Zhang, Ina Yang, Keri Tang, Boxiong Mohseninejad, Leyla Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431069/ http://dx.doi.org/10.1097/01.HS9.0000971348.10013.c4 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Thieblemont, Catherine
Wang, Kaijun
Keeping, Sam
Zhang, Ina
Yang, Keri
Tang, Boxiong
Mohseninejad, Leyla
P1113: COMPARATIVE EFFICACY OF ZANUBRUTINIB (ZANU) VERSUS RITUXIMAB (RTX) IN RELAPSED MARGINAL ZONE LYMPHOMA (MZL): MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)
title P1113: COMPARATIVE EFFICACY OF ZANUBRUTINIB (ZANU) VERSUS RITUXIMAB (RTX) IN RELAPSED MARGINAL ZONE LYMPHOMA (MZL): MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)
title_full P1113: COMPARATIVE EFFICACY OF ZANUBRUTINIB (ZANU) VERSUS RITUXIMAB (RTX) IN RELAPSED MARGINAL ZONE LYMPHOMA (MZL): MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)
title_fullStr P1113: COMPARATIVE EFFICACY OF ZANUBRUTINIB (ZANU) VERSUS RITUXIMAB (RTX) IN RELAPSED MARGINAL ZONE LYMPHOMA (MZL): MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)
title_full_unstemmed P1113: COMPARATIVE EFFICACY OF ZANUBRUTINIB (ZANU) VERSUS RITUXIMAB (RTX) IN RELAPSED MARGINAL ZONE LYMPHOMA (MZL): MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)
title_short P1113: COMPARATIVE EFFICACY OF ZANUBRUTINIB (ZANU) VERSUS RITUXIMAB (RTX) IN RELAPSED MARGINAL ZONE LYMPHOMA (MZL): MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)
title_sort p1113: comparative efficacy of zanubrutinib (zanu) versus rituximab (rtx) in relapsed marginal zone lymphoma (mzl): matching-adjusted indirect comparison (maic)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431069/
http://dx.doi.org/10.1097/01.HS9.0000971348.10013.c4
work_keys_str_mv AT thieblemontcatherine p1113comparativeefficacyofzanubrutinibzanuversusrituximabrtxinrelapsedmarginalzonelymphomamzlmatchingadjustedindirectcomparisonmaic
AT wangkaijun p1113comparativeefficacyofzanubrutinibzanuversusrituximabrtxinrelapsedmarginalzonelymphomamzlmatchingadjustedindirectcomparisonmaic
AT keepingsam p1113comparativeefficacyofzanubrutinibzanuversusrituximabrtxinrelapsedmarginalzonelymphomamzlmatchingadjustedindirectcomparisonmaic
AT zhangina p1113comparativeefficacyofzanubrutinibzanuversusrituximabrtxinrelapsedmarginalzonelymphomamzlmatchingadjustedindirectcomparisonmaic
AT yangkeri p1113comparativeefficacyofzanubrutinibzanuversusrituximabrtxinrelapsedmarginalzonelymphomamzlmatchingadjustedindirectcomparisonmaic
AT tangboxiong p1113comparativeefficacyofzanubrutinibzanuversusrituximabrtxinrelapsedmarginalzonelymphomamzlmatchingadjustedindirectcomparisonmaic
AT mohseninejadleyla p1113comparativeefficacyofzanubrutinibzanuversusrituximabrtxinrelapsedmarginalzonelymphomamzlmatchingadjustedindirectcomparisonmaic

Ejemplares similares